These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2363412)

  • 21. Myelodysplastic syndrome occurring after autologous bone marrow transplantation for lymphoma. Morphologic features.
    Wilson CS; Traweek ST; Slovak ML; Niland JC; Forman SJ; Brynes RK
    Am J Clin Pathol; 1997 Oct; 108(4):369-77. PubMed ID: 9322588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses of hemopoietic precursors to 13-cis retinoic acid and 1,25 dihydroxyvitamin D3 in the myelodysplastic syndromes.
    Swanson G; Picozzi V; Morgan R; Hecht F; Greenberg P
    Blood; 1986 Apr; 67(4):1154-61. PubMed ID: 3513868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
    Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
    Tennant GB; Jacobs A; Bailey-Wood R
    Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis.
    Gold EJ; Conjalka M; Pelus LM; Jhanwar SC; Broxmeyer H; Middleton AB; Clarkson BD; Moore MA
    J Clin Oncol; 1983 Oct; 1(10):627-34. PubMed ID: 6583316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
    Backx B; Broeders L; Touw I; Löwenberg B
    Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
    Merchav S; Wagemaker G; Souza LM; Tatarsky I
    Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic evidence for a clonal involvement of granulocyte-macrophage and erythroid lineages in a patient with refractory anaemia.
    Okuda T; Yokota S; Maekawa T; Sonoda Y; Taniwaki M; Misawa S; Takino T; Abe T
    Acta Haematol; 1988; 80(2):110-5. PubMed ID: 3138872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematologic and cytogenetic analyses of 99 cases of de novo myelodysplastic syndromes.
    D'Emilio A; Montaldi A; Stella M; Celli P; Guercini N; Tremul L; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):61-5. PubMed ID: 8039762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth response to cytokines of circulating myeloid progenitors from myelodysplastic patients at diagnosis and more than 600 days after diagnosis.
    Tennant GB; Bowen DT; Jacobs A
    Eur J Haematol; 1991 Jul; 47(1):65-70. PubMed ID: 1868916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Carlo-Stella C; Cazzola M; Bergamaschi G; Bernasconi P; Dezza L; Invernizzi R; Pedrazzoli P
    Leukemia; 1989 May; 3(5):363-6. PubMed ID: 2654496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-kit ligand augments granulocyte-macrophage colony growth from patients with 5q- syndrome.
    Rosenfeld CS; Nemunaitis J; Sherer CR; Zeigler ZR; Shadduck RK
    Stem Cells; 1993 Nov; 11(6):562-7. PubMed ID: 7509225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological and clinical significance of clonogenic assays in patients with myelodysplastic syndromes.
    Marisavljević D; Rolović Z; Sefer D; Basara N; Ilić D; Bosković D; Colović M
    Med Oncol; 2002; 19(4):249-59. PubMed ID: 12512919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetic evidence for involvement of erythroid and granulocyte/macrophage progenitors in an infant with monosomy 7 syndrome presenting de novo.
    Tachibana N; Raimondi SC; Santana VM; Dow LW
    Med Pediatr Oncol; 1988; 16(2):118-22. PubMed ID: 3352534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
    Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
    Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelodysplastic syndrome with bone marrow eosinophilia: clinical and cytogenetic features.
    Matsushima T; Murakami H; Tsuchiya J
    Leuk Lymphoma; 1994 Nov; 15(5-6):491-7. PubMed ID: 7874007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implications of bone marrow culturing in myelodysplastic syndrome: a retrospective analysis.
    Raymakers R; Preijers F; Boezeman J; Rutten E; De Witte T
    Leuk Lymphoma; 1994 Jun; 14(1-2):111-20. PubMed ID: 7920217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q).
    Geyer JT; Verma S; Mathew S; Wang YL; Racchumi J; Espinal-Witter R; Subramaniyam S; Knowles DM; Orazi A
    Hum Pathol; 2013 Mar; 44(3):346-56. PubMed ID: 22995330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haemopoietic progenitor cells.
    Ohmori M; Ohmori S; Ueda Y; Tohyama K; Yoshida Y; Uchino H
    Br J Haematol; 1990 Feb; 74(2):179-84. PubMed ID: 2180470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.